Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans
Xenon Pharmaceuticals Inc. (XENE) Loan Loss Reserves / Non-Performing Loans data is not available.
| Income Statement Financials | |
-- |
|
$-182.39M |
|
-- |
|
-- |
|
$214.05M |
|
$-214.05M |
|
$31.37M |
|
$-182.69M |
|
$-182.69M |
|
$-182.39M |
|
$-182.39M |
|
$-182.39M |
|
$-182.39M |
|
$-214.05M |
|
$-210.51M |
|
66.89M |
|
66.89M |
|
$-2.73 |
|
$-2.73 |
|
| Balance Sheet Financials | |
$644.96M |
|
$9.65M |
|
$319.84M |
|
$964.80M |
|
$27.27M |
|
-- |
|
$9.60M |
|
$36.88M |
|
$927.92M |
|
$927.92M |
|
$927.92M |
|
75.37M |
|
| Cash Flow Statement Financials | |
$-145.33M |
|
$-117.17M |
|
$353.52M |
|
$57.24M |
|
$148.64M |
|
$91.40M |
|
$32.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.65 |
|
-- |
|
|
Loan Loss Reserves / Non-Performing Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-150.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.66% |
|
-19.66% |
|
-18.90% |
|
-19.66% |
|
$12.31 |
|
$-2.26 |
|
$-2.17 |
|